BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gupta A, Khan AJ, Goyal S, Millevoi R, Elsebai N, Jabbour SK, Yue NJ, Haffty BG, Parikh RR. Insurance Approval for Proton Beam Therapy and its Impact on Delays in Treatment. International Journal of Radiation Oncology*Biology*Physics 2019;104:714-23. [DOI: 10.1016/j.ijrobp.2018.12.021] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Park HS, Yu JB. Proton-Based Chemoradiotherapy-What Level of Evidence Is Necessary to Justify Its Widespread Use? JAMA Oncol 2020;6:246-7. [PMID: 31876903 DOI: 10.1001/jamaoncol.2019.4875] [Reference Citation Analysis]
2 Grzywacz V, Quinn TJ, Wilson T, Reitemeier P, Navin M, Hamstra D, Anderson J, Chinnaiyan P, Stevens C, Kabolizadeh P. Ethical Allocation of Proton Therapy and the Insurance Review Process. Pract Radiat Oncol 2021;11:e449-58. [PMID: 33548544 DOI: 10.1016/j.prro.2021.01.007] [Reference Citation Analysis]
3 Chhabra AM, Choi JI, Hasan S, Press RH, Kabarriti R, Lazarev S, Wolden S, Simone CB 2nd. Insurer's Black Box: Inexplicable Barriers to Proton Therapy Access for Young Adults. Int J Radiat Oncol Biol Phys 2021;110:1538-9. [PMID: 34273325 DOI: 10.1016/j.ijrobp.2021.04.006] [Reference Citation Analysis]
4 Tambas M, Steenbakkers RJ, van der Laan HP, Wolters AM, Kierkels RG, Scandurra D, Korevaar EW, Oldehinkel E, van Zon-meijer TW, Both S, van den Hoek JG, Langendijk JA. First experience with model-based selection of head and neck cancer patients for proton therapy. Radiotherapy and Oncology 2020;151:206-13. [DOI: 10.1016/j.radonc.2020.07.056] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
5 Matson AP, Earp BE, Benavent KA, Geresy KM, Collins JE, Blazar PE. Predictors of Insurance Claim Rejection in Hand and Upper Extremity Surgery. J Am Acad Orthop Surg 2020;28:e662-9. [PMID: 32732658 DOI: 10.5435/JAAOS-D-19-00857] [Reference Citation Analysis]
6 Ning MS, Palmer MB, Shah AK, Chambers LC, Garlock LB, Melson BB, Frank SJ. Three-Year Results of a Prospective Statewide Insurance Coverage Pilot for Proton Therapy: Stakeholder Collaboration Improves Patient Access to Care. JCO Oncol Pract 2020;16:e966-76. [PMID: 32302271 DOI: 10.1200/JOP.19.00437] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Brooks ED, Ning MS, Verma V, Zhu XR, Chang JY. Proton therapy for non-small cell lung cancer: the road ahead. Transl Lung Cancer Res 2019;8:S202-12. [PMID: 31673525 DOI: 10.21037/tlcr.2019.07.08] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
8 Verma V, Ludmir EB, Mesko SM, Brooks ED, Augustyn A, Milano MT, Lin SH, Chang JY, Welsh JW. Commercial Insurance Coverage of Advanced Radiation Therapy Techniques Compared With American Society for Radiation Oncology Model Policies. Pract Radiat Oncol 2020;10:324-9. [PMID: 31446147 DOI: 10.1016/j.prro.2019.08.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mendenhall WM, Smith S, Morris CG, Bradley JA, Mailhot Vega RB, McIntyre K, Klein SL, Mendenhall NP. Insurance Coverage for Adjuvant Proton Therapy in the Definitive Treatment of Breast Cancer. Int J Part Ther 2019;6:26-30. [PMID: 31998818 DOI: 10.14338/IJPT-19-00070.1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Nogueira LM, Jemal A, Yabroff KR, Efstathiou JA. Assessment of Proton Beam Therapy Use Among Patients With Newly Diagnosed Cancer in the US, 2004-2018. JAMA Netw Open 2022;5:e229025. [PMID: 35476066 DOI: 10.1001/jamanetworkopen.2022.9025] [Reference Citation Analysis]
11 Kim H, Srivastava A, Gabani P, Kim E, Lee H, Pedersen KS. Oncology Trainee Perceptions of the Prior Authorization Process: A National Survey. Advances in Radiation Oncology 2022;7:100861. [DOI: 10.1016/j.adro.2021.100861] [Reference Citation Analysis]
12 Torrecillas VF, Neuberger K, Ramirez A, Krakovitz P, Meier JD. What Is the Impact of Prior Authorization on the Incidence of Pediatric Tonsillectomy? Otolaryngol Head Neck Surg 2021;164:1193-9. [PMID: 33170763 DOI: 10.1177/0194599820969631] [Reference Citation Analysis]
13 Patel J, Topf MC, Huntley C, Boon M. Does Insurance Status Impact Delivery of Care with Upper Airway Stimulation for OSA? Ann Otol Rhinol Laryngol 2020;129:128-34. [PMID: 31544468 DOI: 10.1177/0003489419878454] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
14 Forsthoefel MK, Ballew E, Unger KR, Ahn PH, Rudra S, Pang D, Collins SP, Dritschilo A, Harter W, Paudel N, Collins BT, Lischalk JW. Early Experience of the First Single-Room Gantry Mounted Active Scanning Proton Therapy System at an Integrated Cancer Center. Front Oncol 2020;10:861. [PMID: 32547953 DOI: 10.3389/fonc.2020.00861] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Malouff TD, Vallow LA, Seneviratne D, Mahajan A, Foote RL, Hoppe B, Beltran C, Buskirk SJ, Krishnan S, Trifiletti DM. Estimating the Number of Patients Eligible for Carbon Ion Radiotherapy in the United States. Int J Part Ther 2020;7:31-41. [PMID: 33274255 DOI: 10.14338/IJPT-19-00079.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Bishop AJ, Livingston JA, Ning MS, Valdez ID, Wages CA, McAleer MF, Paulino AC, Grosshans DR, Woodhouse KD, Tao R, Roth ME, Gunn GB, McGovern SL. Young Adult Populations Face Yet Another Barrier to Care With Insurers: Limited Access to Proton Therapy. Int J Radiat Oncol Biol Phys 2021;110:1496-504. [PMID: 33677051 DOI: 10.1016/j.ijrobp.2021.02.049] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Tambas M, van der Laan HP, Steenbakkers RJHM, Doyen J, Timmermann B, Orlandi E, Hoyer M, Haustermans K, Georg P, Burnet NG, Gregoire V, Calugaru V, Troost EGC, Hoebers F, Calvo FA, Widder J, Eberle F, van Vulpen M, Maingon P, Skóra T, Weber DC, Bergfeldt K, Kubes J, Langendijk JA. Current practice in proton therapy delivery in adult cancer patients across Europe. Radiother Oncol 2021;167:7-13. [PMID: 34902370 DOI: 10.1016/j.radonc.2021.12.004] [Reference Citation Analysis]
18 Bingham B, Chennupati S, Osmundson EC. Estimating the Practice-Level and National Cost Burden of Treatment-Related Prior Authorization for Academic Radiation Oncology Practices. JCO Oncol Pract 2022;:OP2100644. [PMID: 35201904 DOI: 10.1200/OP.21.00644] [Reference Citation Analysis]
19 Nogueira LM, Sineshaw HM, Jemal A, Pollack CE, Efstathiou JA, Yabroff KR. Association of Race With Receipt of Proton Beam Therapy for Patients With Newly Diagnosed Cancer in the US, 2004-2018. JAMA Netw Open 2022;5:e228970. [PMID: 35471569 DOI: 10.1001/jamanetworkopen.2022.8970] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Yu NY, Sio TT, Mohindra P, Regine WF, Miller RC, Mahajan A, Keole SR. The Insurance Approval Process for Proton Beam Therapy Must Change: Prior Authorization Is Crippling Access to Appropriate Health Care. Int J Radiat Oncol Biol Phys 2019;104:737-9. [PMID: 31204659 DOI: 10.1016/j.ijrobp.2019.04.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
21 Smith GL, Shih YT, Frank SJ. Financial Toxicity in Head and Neck Cancer Patients Treated With Proton Therapy. Int J Part Ther 2021;8:366-73. [PMID: 34285962 DOI: 10.14338/IJPT-20-00054.1] [Reference Citation Analysis]
22 Lin A, Chang JHC, Grover RS, Hoebers FJP, Parvathaneni U, Patel SH, Thariat J, Thomson DJ, Langendijk JA, Frank SJ. PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors. Int J Part Ther 2021;8:84-94. [PMID: 34285938 DOI: 10.14338/IJPT-20-00071.1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Swisher-McClure S, Bekelman JE. It's the Team, Not the Beam. Int J Radiat Oncol Biol Phys. 2019;104:734-736. [PMID: 31204658 DOI: 10.1016/j.ijrobp.2019.02.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
24 Chiang JS, Yu NY, Daniels TB, Liu W, Schild SE, Sio TT. Proton beam radiotherapy for patients with early-stage and advanced lung cancer: a narrative review with contemporary clinical recommendations. J Thorac Dis 2021;13:1270-85. [PMID: 33717598 DOI: 10.21037/jtd-20-2501] [Reference Citation Analysis]
25 Stross WC, Malouff TD, Waddle MR, Miller RC, Peterson J, Trifiletti DM. Proton beam therapy utilization in adults with primary brain tumors in the United States. J Clin Neurosci 2020;75:112-6. [PMID: 32184042 DOI: 10.1016/j.jocn.2020.03.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]